Your fractional CFO for elective medicine practices.
Injectables. Body sculpting. Surgery. Skin rejuvenation. Cosmetic dental. Each modality has different consultation-to-procedure conversion, different patient LTV, different competitive set. Most practices run one funnel for all of them, and miss which modality the funnel is actually working for.
30 minutes, founder-to-founder.
Five operational pains we hear most often
1. Patient acquisition cost has climbed and shows no sign of stopping
Elective-medicine patient acquisition cost has been climbing in many markets. Loyalty ecosystems like Allergan's Allē and Galderma's ASPIRE, alongside paid social and search, increasingly sit between the practice and the patient at the start of the search. Practices winning the math are the ones who built referral and content-led acquisition strong enough to subsidize paid.
2. Consultation-to-procedure conversion is the lever most practices do not measure precisely
Consultation-to-procedure conversion varies widely, and the strongest practices convert well above the typical one. The gap is usually a combination of consultation experience, pricing transparency, and follow-up cadence, none of which most practices can isolate from their own data.
3. Multi-modality reporting hides which modality is actually profitable
Practices running injectables + body sculpting + skin + surgery + sometimes cosmetic dental usually report one combined P&L. The injectables line might be carrying the practice while the surgery line bleeds time. Or the opposite. Without per-modality unit economics, pricing and capacity decisions get made on instinct.
4. Patient reviews and before/after content are the trust currency, and they decay fast
A prospect comparing your practice to the one two blocks over is reading reviews, looking at before/afters, and checking provider credentials. A single bad review can move conversion across the board. Most practices either over-rely on RealSelf without owning their Google + Yelp surface, or vice versa.
5. The geographic competitive set is real and the moat is real
Elective-medicine patients usually shop locally. The practice that wins the prospects closest to it usually wins its market. Practices that try to compete on price across a wide region usually lose to a locally-anchored practice with sharper trust signals.
What another six months of waiting actually costs
Every consultation that stalls for weeks is a consultation that rarely converts. The gap between you and the strongest practices in your market is usually a measurement gap, not a clinical one.
Every procedure-mix decision made on intuition rather than per-service-line economics costs you the high-margin slot. Injectables subsidize laser. Surgery subsidizes injectables. Without per-line P&L, you cannot see which one is the engine and which one is the drag.
Every quarter you are not in the AI-search consideration set for "best plastic surgeon in [your county]" or "best med spa near me" is a quarter your competitors close patients who never knew you existed. A Website Audit reads your site and runs your buyers' questions through the AI assistants, so you see who gets named instead.
Every retention cohort you do not segment is a retention cohort that may be funding the wrong service. Single-procedure patients and repeat injectable patients have very different lifetime value; lumping them in one CAC number hides the engine.
The patient who didn't book today rarely tells you why. The system does.
A deep read, a CFO in the room, and project work
There are a few ways into this, and you do not have to know which one fits today. Start with a finding or an Intro Call; the right depth becomes obvious from there.
A deep read
Understand your own practice, in depth.
Exactly where patient attention and margin leak across injectables, body, skin, surgery, and cosmetic dental.
Website Audit: a three-layer read (classical search, answer-engine, generative AI) of your patient-acquisition surface, with state medical board ad-compliance awareness. Every finding carries severity, evidence, a recommendation, and the expected outcome. The punch list. You leave with a severity-ranked fix list, instead of piecing the problem together yourself from scattered agency opinions. Its price, and Audit Pro's, are on the audit page. View a sample (PDF) →
Website Audit Pro: the Audit plus the synthesized diagnosis. Fix-sequencing, the entity and citation problems the rules cannot reach, and a strategic read. The diagnosis, not just the list. You leave knowing which fixes to make first because they compound, the sequencing done for you rather than left as a list to prioritize on your own.
Buyer Alignment Audit: the patient your public properties actually attract versus the one your modality economics need, with the unit-economics implications of the gap. Usually the right entry point for elective-medicine practices. You leave able to name the patient mix you are actually drawing in and what the mismatch is costing you, without running that analysis yourself.
Full Business Diagnostic Pro: the whole-practice read. It is the Full Business Diagnostic with one addition for a practice competing across several modalities and several competitive sets at once: it breaks every finding out by modality. It sizes the opportunity across five to seven levers and lands a 90-day roadmap. It sizes any upside in your own numbers, and the whole-practice read is assembled for you instead of pieced together across a dozen spreadsheets and meetings.
Ad-compliance awareness, anywhere it appears on this page, is an analytical flag, not legal advice; state medical board rules vary, and your counsel reviews any advertising change.
A CFO in the room
Fractional CFO leadership, two ways in.
The pricing, capacity, modality-mix, and capital decisions too expensive to make alone.
Engage: senior CFO judgment and the intelligence engine alongside your team, on a retainer. A monthly strategic-oversight call, a quarterly review with a refreshed 90-day roadmap, and ongoing tracking of how patients find you, read beside the numbers it moves. The work is structured around the decisions that move your practice, not just activity. It also lifts the data-pulls, the agency status reviews, and the "what does this mean" memos off the owner-provider's desk, time that should go to clinical leadership and patient care. You keep your books; we are the CFO in the room.
Manage: we run the finance function outright. Close, cash, books, dashboard, and the finance-project library as recurring work, with Scott as your fractional CFO. Your finance function runs without you: the close, the cash, the dashboard, and the per-modality reconciliations, all handled. Every major pricing, capacity, and capital call gets CFO judgment before you make it. We own the books.
Where it stops: capital raises, sale processes, lender packages, and succession planning sit outside scope; we refer that work out.
The line between Engage and Manage is who owns the books.
Project work
Hand us the project, scoped to the work. The one-off builds and analyses that do not fit a subscription. We scope the work, price it to the scope, and own delivery end to end.
Modality pricing and mix analysis: what each service line, injectables, body, skin, surgery, cosmetic dental, earns per patient after acquisition cost and provider time, and which lines are priced below what they are worth. You leave knowing what to charge and where the high-margin slots are, the modeling done for you rather than guessed at over a spreadsheet.
Process redesign and automation: the manual, repetitive internal work, the reporting, the reconciliations, the hand-offs between systems, rebuilt and automated. You get time back and a process that does not break when a key person is out.
Other project work too. If it has a defined scope, we can price it and own delivery.
Outcomes, including any time freed and any monetary gains, depend on your current business practices and your own execution. We size and pursue them against your real numbers; we do not promise a figure.
What practice owners ask
Elective medicine runs on multi-procedure mix and the consultation-to-procedure lever. A facial-aesthetic patient may convert to injectables, then to surgery, over years. The CFO work is reading the funnel from initial consultation through lifetime procedure value, by service line, so the marketing spend and the schedule mix decisions both stop being guesses.
Cosmetic surgery, injectables, laser, dermatology, MedSpa, and adult cosmetic ortho all sit in one practice but they have different acquisition costs, lifetime values, and operational cadences. We separate them in the analytics so you can see which service line is actually paying for itself and which is being subsidized by the others.
The Website Audit is a three-layer read (classical search, answer-engine, generative AI) of your own patient-acquisition surface: where visibility, search authority, and AI-search citation rate leak. The Buyer Alignment Audit (usually the right entry point) diagnoses whether the patient mix matches the procedure economics you need. The Full Business Diagnostic Pro is the Full Business Diagnostic broken out by modality: it adds the operational and capital read for each service line.
The Website Audit and Audit Pro publish their prices on the audit page. The Buyer Alignment Audit and Full Business Diagnostic Pro are fixed-price, fixed-scope reads priced at the Intro Call, scoped to your modalities and goals; the Engage and Manage retainers are quoted per client. The fastest way to a number is a 30-minute Intro Call.